Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00817102 · ClinicalTrials.gov registry record · NA
Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses
A NA study, sponsored by Piedmont Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00817102 is a NA study that has completed, run by Piedmont Healthcare. The registered enrollment target is 25 participants.
The verdict
NCT00817102, a NA study, has completed, sponsored by Piedmont Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of CorCTA by comparing the results of the test with another imaging method called Fractional Flow Reserve (FFR), which is done as a part of the cardiac catheterization.
Interventions
- PROCEDURE FFR, IVUS, VH, or combination of the three
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00817102
The ClinicalTrials.gov registry entry for NCT00817102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Piedmont Healthcare, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FFR, IVUS, VH, or combination of the three is the first listed.
NCT00817102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00817102 about?
NCT00817102 is a clinical study titled "Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses". This study will evaluate the effectiveness of CorCTA by comparing the results of the test with another imaging method called Fractional Flow Reserve (FFR), which is done as a part of the cardiac catheterization.
What is the current status of trial NCT00817102?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-11. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00817102?
The interventions under investigation include: FFR, IVUS, VH, or combination of the three (PROCEDURE).
Who is sponsoring clinical trial NCT00817102?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.